Randomized, Controlled Trial of an Electronic Decision Aid for Genetic Testing in Inherited Cancer Syndromes
Massachusetts General Hospital
Summary
This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer
Description
The research study procedures include: screening for eligibility and study questionnaires that would be performed in conjunction with either the genetic counselor visit or use of the electronic decision aid. The study questionnaires include: * Knowledge Survey * Shared Decision Making Process Survey * Decisional Conflict Scale The research study will last up to 2 weeks. It is expected that about 350 people will take part in this research study. The National Cancer Institute (NCI) is supporting this research study by providing funding for the research
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * 18 years or older * Being seen in clinic at Massachusetts General Hospital or Boston Medical Center * Diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma. Exclusion Criteria : * Unable or unwilling to provide informed consent, undergo randomization, or complete the surveys associated with the study * Previous germline genetic testing * History of hereditary pancreatitis * Members of the following vulnerable populations: adults unable to consent, individuals who are not yet adults
Interventions
- BehavioralElectronic Decision Aid
Decision aid followed by an appointment with an oncologist. Will complete surveys/questionnaires
- BehavioralPre-Test Genetic Counseling
Receive pretest counseling with a genetic counselor. Will complete surveys/questionnaires
Locations (2)
- Massachusetts General HospitalBoston, Massachusetts
- Mass General at North Shore Cancer CenterDanvers, Massachusetts